Literature DB >> 20382682

Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.

Gerasimos P Sykiotis1, Xuan-Huong Hoang, Magdalena Avbelj, Frances J Hayes, Apisadaporn Thambundit, Andrew Dwyer, Margaret Au, Lacey Plummer, William F Crowley, Nelly Pitteloud.   

Abstract

CONTEXT: Idiopathic hypogonadotropic hypogonadism (IHH) with normal smell (normosmic IHH) or anosmia (Kallmann syndrome) is associated with defects in the production or action of GnRH. Accordingly, most IHH patients respond to physiological pulsatile GnRH replacement by normalizing serum LH, FSH, and testosterone (T) levels and achieving gametogenesis; some patients, however, show atypical responses. Interestingly, several IHH-associated genes are expressed in multiple compartments of the hypothalamic-pituitary-gonadal axis.
OBJECTIVE: The aim of the study was to investigate whether the clinical, biochemical, or genetic characteristics of IHH men with atypical responses to GnRH indicate alternative or additional defects in the hypothalamic-pituitary-gonadal axis.
SUBJECTS: We studied 90 IHH men undergoing long-term pulsatile GnRH treatment over 30 yr. DESIGN AND
SETTING: We conducted a retrospective study of response to GnRH at a Clinical Research Center.
INTERVENTIONS: Physiological regimens of pulsatile s.c. GnRH were administered for at least 12 months. Dose-response studies using i.v. GnRH pulses assessed the pituitary LH response. MAIN OUTCOME MEASURES: We measured serum T, LH, FSH, and inhibin B levels, sperm in ejaculate, and determined the sequence of IHH-associated genes.
RESULTS: Twenty-six percent of subjects displayed atypical responses to GnRH: 1) 10 remained hypogonadotropic and hypogonadal, demonstrating pituitary and testicular defects; 2) eight achieved spermatogenesis and normal T but only with hypergonadotropism, indicating impaired testicular responsiveness to gonadotropins; and 3) five remained azoospermic despite achieving adult testicular volumes and normal hormonal profiles, suggesting primary defects in spermatogenesis. Mutations were identified only in KAL1 across groups.
CONCLUSION: In addition to hypothalamic GnRH deficiency, IHH men can have primary pituitary and/or testicular defects, which are unmasked by GnRH replacement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382682      PMCID: PMC2902061          DOI: 10.1210/jc.2009-2582

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies.

Authors:  F J Hayes; D J McNicholl; D Schoenfeld; E E Marsh; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

Review 2.  Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.

Authors:  S B Seminara; F J Hayes; W F Crowley
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

3.  Cat eye syndrome with hypogonadotropic hypogonadism.

Authors:  H Masukawa; T Ozaki; T Nogimori
Journal:  Intern Med       Date:  1998-10       Impact factor: 1.271

4.  The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes.

Authors:  C Wechselberger; R Puglisi; E Engel; G Lepperdinger; C Boitani; G Kreil
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

5.  Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome.

Authors:  J P Hardelin; A K Julliard; B Moniot; N Soussi-Yanicostas; C Verney; M Schwanzel-Fukuda; C Ayer-Le Lievre; C Petit
Journal:  Dev Dyn       Date:  1999-05       Impact factor: 3.780

6.  Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.

Authors:  P E Belchetz; T M Plant; Y Nakai; E J Keogh; E Knobil
Journal:  Science       Date:  1978-11-10       Impact factor: 47.728

7.  Inhibin B levels in azoospermic subjects with cytologically characterized testicular pathology.

Authors:  C Foresta; A Bettella; F Petraglia; M Pistorello; S Luisi; M Rossato
Journal:  Clin Endocrinol (Oxf)       Date:  1999-06       Impact factor: 3.478

8.  Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary.

Authors:  J Ericson; S Norlin; T M Jessell; T Edlund
Journal:  Development       Date:  1998-03       Impact factor: 6.868

9.  Localization of fibroblast growth factor 2 (FGF-2) protein and the receptors FGFR 1-4 in normal human seminiferous epithelium.

Authors:  K Steger; F Tetens; J Seitz; C Grothe; M Bergmann
Journal:  Histochem Cell Biol       Date:  1998-07       Impact factor: 4.304

10.  Formation of Rathke's pouch requires dual induction from the diencephalon.

Authors:  N Takuma; H Z Sheng; Y Furuta; J M Ward; K Sharma; B L Hogan; S L Pfaff; H Westphal; S Kimura; K A Mahon
Journal:  Development       Date:  1998-12       Impact factor: 6.868

View more
  36 in total

Review 1.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

Review 2.  The kisspeptin signaling pathway and its role in human isolated GnRH deficiency.

Authors:  Fazal Wahab; Richard Quinton; Stephanie B Seminara
Journal:  Mol Cell Endocrinol       Date:  2011-06-17       Impact factor: 4.102

3.  Expanding the phenotype and genotype of female GnRH deficiency.

Authors:  Natalie D Shaw; Stephanie B Seminara; Corrine K Welt; Margaret G Au; Lacey Plummer; Virginia A Hughes; Andrew A Dwyer; Kathryn A Martin; Richard Quinton; Veronica Mericq; Paulina M Merino; James F Gusella; William F Crowley; Nelly Pitteloud; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

4.  Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.

Authors:  Junjie Zheng; Jiangfeng Mao; Hongli Xu; Xi Wang; Bingkun Huang; Zhaoxiang Liu; Mingxuan Cui; Shuyu Xiong; Wanlu Ma; Le Min; Ursula B Kaiser; Min Nie; Xueyan Wu
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

Review 5.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

6.  Insight Into the Ontogeny of GnRH Neurons From Patients Born Without a Nose.

Authors:  Angela Delaney; Rita Volochayev; Brooke Meader; Janice Lee; Konstantinia Almpani; Germaine Y Noukelak; Jennifer Henkind; Laura Chalmers; Jennifer R Law; Kathleen A Williamson; Christina M Jacobsen; Tatiana Pineda Buitrago; Orlando Perez; Chie-Hee Cho; Angela Kaindl; Anita Rauch; Katharina Steindl; Jose Elias Garcia; Bianca E Russell; Rameshwar Prasad; Uttam K Mondal; Hallvard M Reigstad; Scott Clements; Susan Kim; Kaoru Inoue; Gazal Arora; Kathryn B Salnikov; Nicole P DiOrio; Rolando Prada; Yline Capri; Kosuke Morioka; Michiyo Mizota; Roseli M Zechi-Ceide; Nancy M Kokitsu-Nakata; Cristiano Tonello; Siulan Vendramini-Pittoli; Gisele da Silva Dalben; Ravikumar Balasubramanian; Andrew A Dwyer; Stephanie B Seminara; William F Crowley; Lacey Plummer; Janet E Hall; John M Graham; Angela E Lin; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

7.  Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.

Authors:  Flavia Amanda Costa-Barbosa; Ravikumar Balasubramanian; Kimberly W Keefe; Natalie D Shaw; Nada Al-Tassan; Lacey Plummer; Andrew A Dwyer; Cassandra L Buck; Jin-Ho Choi; Stephanie B Seminara; Richard Quinton; Dorota Monies; Brian Meyer; Janet E Hall; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

8.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

9.  Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.

Authors:  Andrew A Dwyer; Gerasimos P Sykiotis; Frances J Hayes; Paul A Boepple; Hang Lee; Kevin R Loughlin; Martin Dym; Patrick M Sluss; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

10.  Identification of HESX1 mutations in Kallmann syndrome.

Authors:  Kayce Newbern; Nithya Natrajan; Hyung-Goo Kim; Lynn P Chorich; Lisa M Halvorson; Richard S Cameron; Lawrence C Layman
Journal:  Fertil Steril       Date:  2013-03-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.